De-regulated microRNAs in pediatric cancer stem cells target pathways involved in cell proliferation, cell cycle and

Patricia C Sanchez-Diaz1, Tzu-Hung Hsiao, Judy C Chang

  • 1Greehey Children's Cancer Research Institute, University of Texas Health Science Center San Antonio, San Antonio, Texas, United States of America.

Plos One
|April 25, 2013
PubMed
Abstract

Insights

Deregulation of microRNAs (miRNAs) is linked to pediatric cancers. This study identified specific miRNAs targeting key pathways, suggesting potential therapeutic strategies for pediatric cancer stem cells (CSCs).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play crucial roles in biological processes, and their dysregulation is associated with various cancers.
  • The cancer stem cell (CSC) model is increasingly recognized in pediatric cancers.
  • A common miRNA signature in CSCs may underlie disrupted signaling pathways.

Purpose of the Study:

  • To identify deregulated miRNAs within the cancer stem cell (CSC) fraction in pediatric cancers.
  • To elucidate the signaling pathways regulated by these CSC-associated miRNAs.
  • To explore potential therapeutic applications of these findings.

Main Methods:

  • High-throughput quantitative PCR (qPCR) was employed to identify differentially expressed miRNAs (DEmiRs) in CSCs.
  • The BCmicrO algorithm was used to predict potential targets of identified DEmiRs.
  • Pathway analysis (KEGG, Biocarta, Gene Ontology) was performed on predicted targets.

Main Results:

  • 26 CSC-associated DEmiRs were identified.
  • 865 potential CSC-associated DEmiR targets were predicted.
  • Enriched pathways included cell cycle, cell proliferation, p53, and TGF-beta/BMP signaling.
  • Knockdown of specific miRNAs (hsa-miR-21-5p, hsa-miR-181c-5p, hsa-miR-135b-5p) reduced CSC fraction and sphere formation.

Conclusions:

  • CSC-associated DEmiRs and their regulated pathways show promise for therapeutic intervention in pediatric cancers.
  • Targeting these miRNAs could offer novel treatment strategies for pediatric malignancies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.